Evaluation of population-based screening programs on colorectal cancer screening uptake and predictors in Atlantic Canada: insights from a repeated cross-sectional study
- PMID: 39681936
- PMCID: PMC11622942
- DOI: 10.1186/s44263-024-00061-6
Evaluation of population-based screening programs on colorectal cancer screening uptake and predictors in Atlantic Canada: insights from a repeated cross-sectional study
Abstract
Background: Colorectal cancer (CRC) poses a significant public health challenge in Canada, with the Atlantic provinces bearing a particularly high burden. The implementation of population-based colon screening programs is aimed to address this concern. However, limited research exists on the effect of these programs especially in Canada. This study aimed to examine the impact of the first few years of the CRC screening programs in the Atlantic provinces of Canada by assessing changes in screening uptake, barriers, and predictors of screening among eligible populations.
Methods: Employing a repeated cross-sectional design, this study analyzed data from a representative sample of 7614 respondents in 2010 and 6850 in 2017 from the Atlantic provinces aged 50-74 years, extracted from the Canadian Community Health Survey (CCHS). The outcomes measured were CRC screening rates, changes in predictors of screening uptake, and barriers to participation. Potential predictors examined included age, sex, income, education, smoking, and health status.
Results: The proportion of adults aged 50-74 years who meet CRC screening requirements increased from 42% in 2010 to 54% in 2017 yet below the national target of 60%. New Brunswick reported the most significant increase in screening prevalence (18%, p < 0.05). Participation in fecal tests increased from 19.6 to 32.4%. Despite these improvements, disparities in screening participation remained, with lower uptake observed among individuals with lower income and education levels. Age (> 60 years, OR = 2.09, p < 0.01), the presence of multiple chronic health conditions (OR = 2.11, p < 0. 01), being female (OR = 1.21, p < 0.01), married status (OR = 1.21, p < 0.05), access to regular healthcare (OR = 1.91, p < 0.01), and nonsmoking status (OR = 2.55, p < 0.01) were identified as significant predictors of CRC screening uptake.
Conclusions: This study shows that while CRC screening uptake increased across the Atlantic provinces between 2010 and 2017, barriers to and disparities in screening participation persist. This highlights the need for targeted interventions to improve awareness, access, and screening uptake, particularly among disadvantaged groups, to promote equitable healthcare outcomes. Continued efforts should focus on reducing barriers to screening and leveraging available evidence to inform interventions aimed at mitigating the CRC burden in the region.
Keywords: Atlantic Canada; Cancer prevention; Cancer screening; Colorectal cancer; Health determinants; Healthcare disparities.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The exclusive use of secondary data from Statistics Canada exempted this study from review by the Health Research Ethics Board (HREB) of Memorial University of Newfoundland. Based on guidance in the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans — TCPS 2 (a joint policy of Canada’s three federal research agencies — the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC), and the Social Sciences and Humanities Research Council of Canada (SSHRC) or “the Agencies”): Research that relies exclusively on information that is made available through legislation or regulation does not require REB review (Article 2.2). Exemption from REB review for research involving this type of information is based on the presence of a custodian/steward designated in accordance with access to information and privacy legislation who protects privacy and proprietary interests associated with the information (e.g., an access to information and privacy coordinator or a guardian of Canadian census data). Tri-Council Policy Statement is available at https://ethics.gc.ca/eng/policy-politique_tcps2-eptc2_2022.html . Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
Racial and sociodemographic distribution of colorectal cancer screening in Canada: A cross-sectional study.Can J Public Health. 2024 Jun;115(3):371-383. doi: 10.17269/s41997-024-00859-9. Epub 2024 Mar 14. Can J Public Health. 2024. PMID: 38485885 Free PMC article.
-
Examining Racial Disparities in Colorectal Cancer Screening and the Role of Online Medical Record Use: Findings From a Cross-Sectional Study of a National Survey.JMIR Cancer. 2024 Dec 4;10:e53229. doi: 10.2196/53229. JMIR Cancer. 2024. PMID: 39631060 Free PMC article.
-
Screening rates for colorectal cancer in Canada: a cross-sectional study.CMAJ Open. 2015 Apr 2;3(2):E149-57. doi: 10.9778/cmajo.20140073. eCollection 2015 Apr-Jun. CMAJ Open. 2015. PMID: 26389092 Free PMC article.
-
Effective strategies for Fecal Immunochemical Tests (FIT) programs to improve colorectal cancer screening uptake among populations with limited access to the healthcare system: a rapid review.BMC Health Serv Res. 2024 Jan 23;24(1):128. doi: 10.1186/s12913-024-10573-4. BMC Health Serv Res. 2024. PMID: 38263112 Free PMC article. Review.
-
Colorectal cancer prevention in Central, Eastern European and South Caucasus countries: a review of policy approaches.J Health Organ Manag. 2024 May 28;ahead-of-print(ahead-of-print). doi: 10.1108/JHOM-02-2023-0030. J Health Organ Manag. 2024. PMID: 38796752 Review.
Cited by
-
Evidence on global public health cancer strategies.BMC Glob Public Health. 2025 Aug 20;3(1):72. doi: 10.1186/s44263-025-00197-z. BMC Glob Public Health. 2025. PMID: 40835952 Free PMC article. No abstract available.
-
The Role of Proteomics and Genomics in the Development of Colorectal Cancer Diagnostic Tools and Potential New Treatments.ACS Pharmacol Transl Sci. 2025 Apr 10;8(5):1227-1250. doi: 10.1021/acsptsci.4c00686. eCollection 2025 May 9. ACS Pharmacol Transl Sci. 2025. PMID: 40370990 Review.
-
A Cohort Study Analysing the Impact of the COVID-19 Pandemic on Colorectal Cancer Presentations in a Medium-Large Canadian Community Hospital.Cancer Control. 2025 Jan-Dec;32:10732748251356926. doi: 10.1177/10732748251356926. Epub 2025 Jul 2. Cancer Control. 2025. PMID: 40600849 Free PMC article.
References
-
- Cancer Canadian Partnership Against. Colorectal Screening in Canada: 2019/2020 Environmental Scan. Toronto: Canadian Partnership Against Cancer; 2021.
-
- Canadian Cancer Society. Canadian Cancer Statistics: a 2022 special report on cancer prevalence. Toronto: Canadian Cancer Statistics Advisory Committee; 2022.
LinkOut - more resources
Full Text Sources